Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-29

Clinical Trial Update: Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx® [NA]

View source ↗

Summary

A completed clinical trial evaluating Metanx for restoration of cutaneous sensation in patients with diabetic peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metanx

Snippet

Sponsor: Carolina Musculoskeletal Institute | Conditions: Diabetic Peripheral Neuropathy | NA | Status: COMPLETED